The real story behind GSK’s whistleblower scandal
Back in 2014, GlaxoSmithKline made headlines around the world after a whistleblower complaint revealed sweeping corruption in its Chinese operation, including the bribery of doctors with cash and sexual favors. It resulted in a prison sentence and a $500 million fine, and the world just moved on.
But that wasn’t the entire story. As David Barboza of the Wire reports, GSK appears to have singled out the wrong employee in its hunt for the whistleblower. The company never caught the actual person who tipped off authorities, Barboza writes, and the real whistleblower has new details and some outstanding questions.
Among them is whether a reward is in the offing. Under federal law, whistleblowers whose tips lead to successful prosecutions are eligible for payouts. And yet a decade after first reporting on GSK’s malfeasance, the whistleblower is yet to yet to hear from U.S. authorities.
Read more.
But that wasn’t the entire story. As David Barboza of the Wire reports, GSK appears to have singled out the wrong employee in its hunt for the whistleblower. The company never caught the actual person who tipped off authorities, Barboza writes, and the real whistleblower has new details and some outstanding questions.
Among them is whether a reward is in the offing. Under federal law, whistleblowers whose tips lead to successful prosecutions are eligible for payouts. And yet a decade after first reporting on GSK’s malfeasance, the whistleblower is yet to yet to hear from U.S. authorities.
Read more.
.png)
No hay comentarios:
Publicar un comentario